Olathe-based Metactive lands $1.5M, two medical patents
March 21, 2017 | Meghan LeVota
Olathe-based medical device company Metactive released a pair of positive announcements for the firm.
Dr. Nick Franano
In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.
Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.
CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.
“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”
Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.
Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.
2017 Startups to Watch
stats here
Related Posts on Startland News
KC newbie Rex tops $1M in revenue, kicks off hiring
Surging growth at one of Kansas City’s newest startups is leading it to hire a staff six times its current size. Rex, an animal health tech company that recently graduated from the Techstars-led Sprint Accelerator, is hoping to quickly boost its headcount from two to 12. In the days following a pitch at the accelerator’s…
ShotTracker, NBA champ Klay Thompson set for virtual camp
The Golden State Warriors weren’t the only team elated from its Tuesday night NBA Championship win over the Cleveland Cavaliers. Overland Park-based ShotTracker also snagged a win alongside the Warriors’ first championship since 1975, as the wearable tech firm’s recent endorsement deal with Golden State guard Klay Thompson received another coat of varnish. Golden State’s…
Digital Sandbox helps entrepreneurs fight summer slump
With summer knocking at the door, Digital Sandbox KC is taking initiative to provide resources and instruction to keep entrepreneurs engaged and on-point. Digital Sandbox, a proof-of-concept program that expedites area businesses’ projects, will host the third-annual “Summer in the Sand Series” as a way of prompting discussion around relevant topics for entrepreneurs. “The Summer…
Techstars acquires UP Global, expands KC footprint
The global business accelerator firm that operates the Sprint Mobile Health Accelerator announced a major acquisition Tuesday that will expand its reach in Kansas City. Boulder-based Techstars reported Tuesday morning that it acquired UP Global, an international non-profit that fosters entrepreneurship with a variety of events and programs around the world. UP Global operates the…